Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
03/2003
03/13/2003CA2458780A1 Targeted nucleic acid constructs and uses related thereto
03/13/2003CA2458682A1 Nanoparticles comprising biologically active tnf which is immobilised on the same
03/13/2003CA2458613A1 Light-stabilized in vivo stain composition and method of manufacture
03/12/2003EP1290461A1 Method for investigating the fate of a test compound or the state of a biological system by means of nmr of hyperpolarised nmr active nuclei
03/12/2003EP1290187A2 Humain kinases
03/12/2003EP1290148A2 AMINOACYL tRNA SYNTHETASES
03/12/2003EP1290035A1 Fluorescein isothiocyanate (fitc) sinistrin, its production and use
03/12/2003EP1289571A2 Prochelators of radiometal labeled molecules
03/12/2003EP1289569A1 Diagnosing colic type in an infant
03/12/2003EP1289565A2 Compounds for targeting endothelial cells
03/12/2003EP1289562A2 Novel of preparation hypericin bonded with poly-n-vinylamides
03/12/2003EP1289414A2 Combined impedance imaging and mammography
03/12/2003EP1137443B1 Magnetic resonance tomography contrast agent
03/12/2003EP1075285B1 The use of a vital dye for facilitating surgical procedures for cataract extraction
03/12/2003EP1041967B1 Microparticles and their therapeutic or diagnostic use
03/12/2003CN1402640A Stabilized liquid polypeptide-confg. pharmaceutical compositions
03/12/2003CN1401629A Image forming agent, its precursor and preparing process thereof
03/12/2003CN1401393A All-digestive tract microcapsule non-invasive introduced diagnostic and examination system
03/11/2003US6531138 Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypetides and peptides in the diagnostic of tuberculosis
03/11/2003US6531111 High viscosity embolizing compositions
03/06/2003WO2003019142A2 Compositions and methods for detection and regulation of genes associated with ruptured atherosclerotic plaque
03/06/2003WO2003018640A2 Use of heparinoid derivatives for treating and diagnosing diseases that can be treated by heparinoids
03/06/2003WO2003018612A2 Extracellular messengers
03/06/2003WO2003018530A1 1,3-glyceride compound having two iodophenyl groups
03/06/2003WO2003018068A1 Ocular diagnosis of alzheimer's disease
03/06/2003WO2003018067A1 Contact agent for ultrasound diagnosis
03/06/2003WO2003018036A1 Composition for detection and/or treatment of lesions & tumours
03/06/2003WO2003017818A2 Management of gastro-intestinal disorders
03/06/2003WO2003006069A9 Imaging infection using fluorescent protein as a marker
03/06/2003WO2002099422A3 Individualization of therapy with alzheimer's disease agents
03/06/2003WO2002096367A3 Targeted multivalent macromolecules
03/06/2003WO2002089794A8 Method for treating neuropathic pain and pharmaceutical preparation therefor
03/06/2003WO2002074243A9 Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders
03/06/2003WO2001092304A3 Transporters and ion channels
03/06/2003US20030046718 Administering compounds having an effect on cardiac fibrosis, myocardial infarction, defects in electrical conductance, atherosclerosis, unstable plaque, and stroke in an animal which does not express an active SR-BI, and an apolipoprotein
03/06/2003US20030045705 Backbone modified oligonucleotide analogues
03/06/2003US20030044993 13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control
03/06/2003US20030044355 Supplying contrast agent in microbubbles which reradiates ultrasonic frequency; detection
03/06/2003US20030044354 Gas microsphere liposome composites for ultrasound imaging and ultrasound stimulated drug release
03/06/2003US20030044351 Viscosity calibration
03/06/2003CA2458445A1 Extracellular messengers
03/06/2003CA2457846A1 Use of heparinoid derivatives for treating and diagnosing diseases that can be treated by heparinoids
03/05/2003EP1287833A2 Liposome containing hydrophobic iodine compound and X-ray contrast medium comprising said liposome
03/05/2003EP1287359A1 Coated nanoparticles
03/05/2003EP1287141A2 Extracellular messengers
03/05/2003EP1287130A2 Mammalian cytokine receptor subunit proteins, related reagents and methods
03/05/2003EP1286697A2 Method for selectively inhibiting ghrelin action
03/05/2003EP1183255B1 Bicyclic polyaminoacid metal complexes, method for preparing same and use in medical imaging
03/05/2003EP1027077B1 Magnetic resonance imaging agents for the delivery of therapeutic agents
03/05/2003EP0971692B1 Specific magnetosome, method for the production and use thereof
03/05/2003EP0939622B1 Porous microcapsules and their use as therapeutic and diagnostic vehicles
03/05/2003EP0724457B1 Radiation sensitization using texaphyrins
03/05/2003EP0712293B1 Method of preparing gas-filled lipid microspheres and gas-filled lipid microspheres
03/05/2003EP0669913B1 Detection of hypoxia
03/05/2003CN1102411C Preparation for detecting urease activity in stomach
03/04/2003US6528245 Bone marrow cells as a source of neurons for brain and spinal cord repair
03/04/2003US6528067 Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof
03/04/2003US6528039 Low density microspheres and their use as contrast agents for computed tomography and in other applications
03/04/2003US6528038 An immune response directed against Porphyromonas gingivalis. The composition includes a suitable adjuvant and/or acceptable carrier and one substantially purified P. gingivalis immunogen. The immunogen is selected from the group consisting
03/04/2003US6526778 Resilient containers for hyperpolarized gases and associated methods
02/2003
02/27/2003WO2003016923A2 Hydroxypyridonate and hydroxypyrimidinone chelating agents
02/27/2003WO2003016549A2 Nucleic-acid associated proteins
02/27/2003WO2003015850A1 Method for inducing selectively suppressed immune response
02/27/2003WO2003015832A1 Diagnostic agent for pancreatic exocrine function
02/27/2003WO2003015831A1 Gas microsphere liposome composites
02/27/2003WO2003015829A2 Methods of determining the effects of toxins
02/27/2003WO2003015796A1 Imunogenic conjugate of carbohydrate haptens and aggregated protein carrier
02/27/2003WO2003015785A1 2h-phthalazin-1-ones and methods for use thereof
02/27/2003WO2003015756A1 Preparation of microparticles
02/27/2003WO2003015745A1 Expandable gastric retention device
02/27/2003WO2003015626A2 Method and device for determining a characteristic value relating to the blood circulation of modified tissue regions in organs of living beings
02/27/2003WO2003015617A2 Assay method for alzheimer's disease
02/27/2003WO2003015606A2 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy
02/27/2003WO2003015507A1 Development of transgenic model for interventions in neurodegenerative diseases
02/27/2003WO2002081634A3 Imaging nucleic acid delivery
02/27/2003WO2002080774A3 Method for improved measurement of local physical parameters in afluid-filled cavity
02/27/2003WO2002078611A3 Echogenic polymer microcapsules and nanocapsules and methods for production and use thereof
02/27/2003WO2002067850A3 B/b-like fragment targeting for the purposes of photodynamic therapy and medical imaging
02/27/2003WO2002031161A3 Regulation of human phospholipase-like enzyme
02/27/2003WO2002030471A3 A novel system for the evaluation of the activity and/or specificity of a viral component
02/27/2003US20030041340 Animal model for fatty acid amide-related neurobehaviors
02/27/2003US20030040756 Medico-surgical devices
02/27/2003US20030040083 Dual specificity antibodies and methods of making and using
02/27/2003US20030040028 Analgesic screening method and composition
02/27/2003US20030039997 Pentopyranosyl nucleic acid arrays, and uses thereof
02/27/2003US20030039959 Detection of premature tumor cells in mammary gland tissue; obtain mammary gland tissue, incubate with diagnostic agent, monitor sample for binding and signal, presence of signal indicates premature cancer
02/27/2003US20030039683 Multilayer binding; lamellar surface structure
02/27/2003US20030039613 Novel therapeutic delivery systems
02/27/2003CA2458643A1 Nucleic-acid associated proteins
02/27/2003CA2458193A1 Development of transgenic model for interventions in neurodegenerative diseases
02/27/2003CA2456988A1 Gas microsphere liposome composites
02/27/2003CA2456985A1 2h-phthalazin-1-ones and methods for use thereof
02/27/2003CA2456976A1 Expandable gastric retention device
02/27/2003CA2456161A1 Hydroxypyridonate and hydroxypyrimidinone chelating agents
02/27/2003CA2454853A1 Imunogenic conjugate of carbohydrate haptens and aggregated protein carrier
02/26/2003EP1285063A1 Anti-angiogenic polypeptides
02/26/2003EP1284958A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoidane derivatives
02/26/2003EP1284952A1 Substituted chalcones as therapeutic compounds
02/26/2003EP1284727A1 Intracorporeal medicaments for photodynamic treatment of disease
02/26/2003EP1284654A2 Medical optical imaging scanner using multiple wavelength simultaneous data acquisition for breast imaging
1 ... 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 ... 354